Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04988438
Other study ID # 2021/1407-03UHD
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 15, 2021
Est. completion date August 31, 2023

Study information

Verified date September 2021
Source University Hospital Dubrava
Contact Žarko Babic, prof.dr.sc.
Phone +38512903390
Email zarko.babic@zg.t-com.hr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The patients who had COVID-19 infection, and after that reported for one of the signs of gastrointestinal disorder (esophageal and anorectal) will be underwent to esophageal and anorectal motor monitoring investigation (HRM manometry) on standard protocol.


Description:

The patients who had COVID-19 infection, and after that reported for one of the signs of gastrointestinal (esophageal and anorectal disorder) will be underwent to esophageal and anorectal motor monitoring investigation (HRM manometry) on standard protocol. The patients with dysphagia, chest discomfort during swallowing, or chest pain during swallowing, patients with obstipation, fecal evacuation symptoms, lower stomach discomfort before defecation etc. will be included in the study. In all of them other gastrointestinal diseases will be excluded by standard routine laboratory investigation, ultrasound, routine endoscopy investigation and 24 hours impedance pH-measurement. After manometric measurement of esophagus and anorectal region to standard protocol by using MMS-HRM 360 monitoring system with 36 canals catheter for esophagus and 24 canals catheter for anorectal monitoring, data will be calculated by using statistics.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date August 31, 2023
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - Patients with esophageal and anorectal symptoms after COVID 19- infection - Patients with worsening of esophageal and anorectal symptom after COVID 19- infection, but who had previously described esophageal and anorectal symptoms Exclusion Criteria: - Other gastrointestinal disease that can influence to results - Gastroesophageal reflux - H. Pylori infection - Bacterial, parasitic, viral and fungal gastrointestinal infection or infestation - Myasthenia - Scleroderma - Diabetes mellitus - Thyroidal hyperfunction

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Croatia Prof.dr.sc. Žarko Babic, FEBGH Zagreb Select State

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Dubrava

Country where clinical trial is conducted

Croatia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of esophageal parameters 1 on manometry In esophagus we will measure Upper and lower esophageal sphincter pressure in mmHg. 120 days
Primary Measurement of esophageal parameters 2 on manometry In esophagus we will measure Integrated relaxation pressure (IRP) in mmHg. 120 days
Primary Measurement of esophageal parameters 3 on manometry In esophagus we will measure Contractile front velocity (CVF) in cm/s. 120 days
Primary Measurement of esophageal parameters 4 on manometry In esophagus we will measure Distal contractile integral (DCI) in mmHg.s.cm. 120 days
Primary Measurement of esophageal parameters 5 on manometry In esophagus we will measure Distal latency (DL) in seconds. 120 days
Primary Measurement of esophageal parameters 6 on manometry In esophagus we will measure Peristaltic brake (BR) in cm. 120 days
Primary Measurement of anorectal parameters 1 on manometry On anorectal manometry we will measure Resting test pressure in mmHg. 2 years
Primary Measurement of anorectal parameters 2 on manometry On anorectal manometry we will measure Squeeze test pressure in mmHg. 2 years
Primary Measurement of anorectal parameters 3 on manometry On anorectal manometry we will measure Endurance squeeze test pressure in mmHg. 2 years
Primary Measurement of anorectal parameters 4 on manometry On anorectal manometry we will measure recto-anal inhibitory reflex test (RAIR)- relaxation in percent. 2 years
Primary Measurement of anorectal parameters 5 on manometry On anorectal manometry we will measure Push test pressure in mmHg. 2 years
Primary Measurement of anorectal parameters 6 on manometry On anorectal manometry we will measure Sensation test with ml in balloon. 2 years
Primary Measurement of anorectal parameters 7 on manometry On anorectal manometry we will measure Balloon expulsion test as positive or negative. 2 years
See also
  Status Clinical Trial Phase
Completed NCT04429802 - The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity N/A
Completed NCT01644240 - A Phase 1, Multiple Intravenous Dose Study to Examine the Safety, Tolerability, and Pharmacokinetics of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects Phase 1
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Terminated NCT02573519 - Gastrointestinal Motility Among Diabetes Patients N/A
Recruiting NCT04764019 - Intestinal Dysmotility in Patients With Functional Digestive Symptoms N/A
Completed NCT03012594 - Lanreotide in the Treatment of Small Bowel Motility Disorders Phase 2
Not yet recruiting NCT05268328 - The Effect of Foot Reflexology After Cesarean Section
Completed NCT02245165 - Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades Phase 1
Completed NCT03552510 - Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility N/A
Completed NCT01394055 - Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis Phase 1
Active, not recruiting NCT00793195 - Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants? Phase 2
Recruiting NCT04208828 - IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Active, not recruiting NCT06347367 - Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention N/A
Recruiting NCT05989763 - Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis N/A
Completed NCT01635608 - Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water Phase 1